CNSP Company Profile and Key Details

Q: Who are the executives of CNSP?

Mr. Christopher S. Downs C.P.A., CTP, FP&AChief Financial OfficerMr. John Michael Climaco Esq., J.D.Chief Executive Officer, Pres & DirectorDr. Donald H. Picker Ph.D.Chief Scientific OfficerMr. Christopher S. Downs CPA, CTP, FP&AChief Financial OfficerDr. Waldemar Priebe Ph.D.Co-Founder, Founding Scientist & Chairman of Scientific Advisory BoardDr. Sandra L. Silberman M.D., Ph.D.Chief Medical Officer of New Products

NASDAQ : CNSP

CNS Pharmaceuticals

$5.39

0.0014+0.03%

Open: 9:55 AM

69.62

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

CNS Pharmaceuticals, Inc. (CNSP) stock surged +0.03%, trading at $5.39 on NASDAQ, up from the previous close of $5.39. The stock opened at $5.39, fluctuating between $5.20 and $5.39 in the recent session.

Stock Snapshot

5.39

Prev. Close

3.1M

Market Cap

5.2

Day Low

-0.22

P/E Ratio

-24.57

EPS (TTM)

-2.51

Cash Flow per Share

5.39

Open

574.58K

Number of Shares

5.3914

Day High

91.54%

Free Float in %

-0.79

Book Value

1.03K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 21, 2026	5.68	5.68	5.29	5.39	20.07K
Jul 20, 2026	5.01	5.50	5.01	5.50	16.09K
Jul 17, 2026	4.83	5.05	4.66	5.04	7.59K
Jul 16, 2026	4.66	5.22	4.65	4.74	10.01K
Jul 15, 2026	4.91	4.91	4.61	4.68	4.17K
Jul 14, 2026	5.04	5.04	4.80	4.86	4.15K
Jul 13, 2026	4.99	5.27	4.95	5.09	3.71K
Jul 10, 2026	5.23	5.23	5.17	5.17	4.31K
Jul 09, 2026	4.98	5.35	4.98	5.32	9.3K
Jul 08, 2026	5.21	5.40	5.09	5.40	13.38K
Jul 07, 2026	4.85	5.45	4.37	5.11	19.41K
Jul 06, 2026	5.07	5.07	4.90	4.98	11.45K
Jul 02, 2026	5.02	5.07	4.66	5.07	10.21K
Jul 01, 2026	4.89	4.95	4.53	4.68	14.35K
Jun 30, 2026	4.18	4.90	4.10	4.78	17.22K
Jun 29, 2026	4.10	4.39	4.00	4.15	11.17K
Jun 26, 2026	4.01	4.20	3.90	3.98	15.83K
Jun 25, 2026	4.02	4.20	4.00	4.15	7.61K
Jun 24, 2026	4.22	4.29	3.95	4.17	13.6K
Jun 23, 2026	4.25	4.36	4.25	4.29	6.85K

Contact Details

Houston, TX 77027

United States

https://www.cnspharma.com 800 946 9185

About Company

CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily focused on developing innovative anti-cancer therapies for tumors affecting the brain and central nervous system. Its primary investigational compound, Berubicin, an anthracycline, is currently progressing through Phase I and II clinical trials as a potential treatment for glioblastoma multiforme, an aggressive form of brain cancer. To bolster its research and development initiatives, the company has entered into several strategic agreements. These include licensing arrangements with Houston Pharmaceuticals, Inc., The University of Texas M.D. Anderson Cancer Center, and Animal Life Sciences, LLC. Additionally, CNS Pharmaceuticals has a development agreement in place with WPD Pharmaceuticals Inc. and a collaborative partnership with Reata Pharmaceuticals, Inc. The company was founded in 2017 and is headquartered in Houston, Texas.

Stock Peers

ARGX

28.55+3.37%

argenx SE$874.74 REGN

3.04+0.45%

Regeneron Pharmaceuticals, Inc.$675.19 MDGL

11.1+2.07%

Madrigal Pharmaceuticals, Inc.$546.79 UTHR

6.49+1.23%

United Therapeutics Corporation$535.83 VRTX

1.5+0.31%

Vertex Pharmaceuticals Incorporated$482.00 KRYS

-0.16-0.05%

Krystal Biotech, Inc.$339.06 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ONC

8.11+2.61%

BeOne Medicines AG$318.69 PRAX

13.44+4.41%

Praxis Precision Medicines, Inc.$317.87 LGND

11.48+3.90%

Ligand Pharmaceuticals Incorporated$305.47

Frequently Asked Questions

What is the current CNS Pharmaceuticals, Inc. (CNSP) stock price?

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) stock price is $5.39 in the last trading session. During the trading session, CNSP stock reached the peak price of $5.39 while $5.20 was the lowest point it dropped to. The percentage change in CNSP stock occurred in the recent session was 0.03% while the dollar amount for the price change in CNSP stock was $0.00.

CNSP's industry and sector of operation?

The NASDAQ listed CNSP is part of Biotechnology industry that operates in the broader Healthcare sector. CNS Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of CNSP?

Mr. Christopher S. Downs C.P.A., CTP, FP&A
Chief Financial Officer
Mr. John Michael Climaco Esq., J.D.
Chief Executive Officer, Pres & Director
Dr. Donald H. Picker Ph.D.
Chief Scientific Officer
Mr. Christopher S. Downs CPA, CTP, FP&A
Chief Financial Officer
Dr. Waldemar Priebe Ph.D.
Co-Founder, Founding Scientist & Chairman of Scientific Advisory Board
Dr. Sandra L. Silberman M.D., Ph.D.
Chief Medical Officer of New Products

How CNSP did perform over past 52-week?

CNSP's closing price is 183.68% higher than its 52-week low of $1.90 where as its distance from 52-week high of $10.59 is -49.09%.

How many employees does CNSP have?

Number of CNSP employees currently stands at 8.

Link for CNSP official website?

Official Website of CNSP is: https://www.cnspharma.com

How do I contact CNSP?

CNSP could be contacted at phone 800 946 9185 and can also be accessed through its website. CNSP operates from 2100 West Loop South, Houston, TX 77027, United States.

How many shares of CNSP are traded daily?

CNSP stock volume for the day was 1.03K shares. The average number of CNSP shares traded daily for last 3 months was 1.45M.

What is the market cap of CNSP currently?

The market value of CNSP currently stands at $3.10M with its latest stock price at $5.39 and 574.58K of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	8
Beta	1.02
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	8
Beta	1.02
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

CNSP Company Profile and Key Details

CNS Pharmaceuticals

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Company Overview

Earnings & Analyst Outlook

Shareholding & Insider Activity

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Key Takeaways

Price Forecast & Outlook

Valuation Metrics